Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Immunovant, Inc. publishes a filing, an earnings call transcript or a press release.

Get IMVT alerts

About Matt Gline

Matt Gline is recorded as CEO at Immunovant, Inc. (IMVT). Matt Gline has spoken on 1 earnings call across 1 company, most recently for Immunovant, Inc. on February 6, 2026. Immunovant, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Immunovant, Inc. includes Eric Venker (CEO), Eric Venker, M.D. (CEO and Board Member), Eric Venker, M.D., Pharm.D. (CEO) and 7 others.

Matt Gline on recent calls

“I'm going to start our presentation on slide five. You know, I was sitting, talking to the team, it was about a week ago today, looking at a draft of this morning's presentation and thinking that it was going to be a pretty boring 10Q. We had gotten together in December for the Investor Day.”
CEO, Roivant 3Q 2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Immunovant, Inc.

Recent activity